MODULAR CONSTRUCTION OF THE BACTERIAL LIPIDATION-BASED SARS-COV-2 MUCOSAL NANOVACCINE. (IMAGE)

KeAi Communications Co., Ltd.

MODULAR CONSTRUCTION OF THE BACTERIAL LIPIDATION-BASED SARS-COV-2 MUCOSAL NANOVACCINE.

Caption

Modular construction of the bacterial lipidation-based SARS-CoV-2 mucosal nanovaccine.

Credit

Jun Wu, et al

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.

License

CC BY-NC-ND

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.